Julian Baker’s Galmed Pharmaceuticals GLMD Stock Holding History

Julian Baker’s Portfolio GLMD Stock Details GLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-128	Closed	-$634K	–	122
2021 Q1	$634K	Hold	128	–	–	﹤0.01%	123
2020 Q4	$575K	Sell	128 -15	-10%	-$74.9K	﹤0.01%	123
2020 Q3	$725K	Sell	143 -7	-5%	-$45.7K	﹤0.01%	114
2020 Q2	$1.03M	Hold	150	–	–	﹤0.01%	107
2020 Q1	$746K	Hold	150	–	–	﹤0.01%	102
2019 Q4	$1.25M	Hold	150	–	–	0.01%	89
2019 Q3	$1.03M	Hold	150	–	–	0.01%	98
2019 Q2	$1.58M	Hold	150	–	–	0.01%	89
2019 Q1	$1.76M	Hold	150	–	–	0.01%	84
2018 Q4	$1.47M	Sell	150 -75	-33%	-$1.05M	0.01%	79
2018 Q3	$4.4M	Sell	225 -217	-49%	-$4.06M	0.03%	73
2018 Q2	$7.57M	Buy	+442	New	+$5.12M	0.06%	61

Other funds holding GLMD

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Ibex Investors Denver, Colorado $194M AUM 23.58% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

PAWC

P.A.W. Capital Greenwich, Connecticut $131M AUM 46.14% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Julian Baker's GLMD Position: Q2 2021 in Review

Julian Baker sold out of Galmed Pharmaceuticals (GLMD) in Q2 2021, closing a stake of 128 shares — an estimated $634K sold.

Julian Baker first reported a position in GLMD in Q2 2018 and held it in 12 quarters. The position peaked at $7.57M in Q2 2018. 22 funds tracked by Wall St. Rank hold GLMD as of Q2 2021.

Julian Baker reported no remaining Galmed Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Julian Baker sold 128 Galmed Pharmaceuticals shares in Q2 2021, an estimated $634K.
Julian Baker first reported a position in Galmed Pharmaceuticals in Q2 2018 and held it in 12 quarters.
Julian Baker's Galmed Pharmaceuticals position peaked at $7.57M in Q2 2018.
22 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q2 2021.

Based on Baker Bros. Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.